𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of apoptosis in Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis

✍ Scribed by Jun-ichi Kawada; Hiroshi Kimura; Yukiko Shibata; Shinya Hara; Yo Hoshino; Seiji Kojima; Kazuo Nishikawa; Tsuneo Morishima


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
146 KB
Volume
78
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Epstein-Barr virus (EBV) is known to be a causative agent of hemophagocytic lymphohistiocytosis (HLH). To investigate association of apoptosis in the pathogenesis of EBV-associated HLH, the serum EBV loads, and serum concentrations of soluble tumor necrosis factor receptor 1 (sTNF-R1), soluble Fas ligand, and cytochrome c were examined in 15 patients with EBVassociated HLH and 24 patients with infectious mononucleosis (IM). Levels of sTNF-R1 are known to reflect the biological activity of TNF-a and cytochrome c is a specific marker of apoptosis. EBV loads, and concentrations of sTNF-R1 and cytochrome c were significantly higher in patients with EBV-associated HLH than in patients with IM. On the other hand, there were no statistically significant differences in the concentrations of soluble Fas ligand. In patients with EBVassociated HLH, EBV loads, concentrations of sTNF-R1, and cytochrome c were correlated with each other. These results suggest that apoptosis, which is dependent on the EBV load and could be mediated by TNF-a, plays a major role in the pathophysiology of EBV-associated HLH.


📜 SIMILAR VOLUMES


Biomarker and morphological characterist
✍ Imashuku, Shinsaku; Hibi, Shigeyoshi; Tabata, Yasuhiro; Sako, Masahiro; Sekine, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB

## Background. Viruses may induce primary as well as secondary hemophagocytic lymphohistiocytosis (HLH), but it may not be possible to discriminate between these two in patients with a negative family history. Among these HLH cases, fulminant and fatal virus-associated hemophagocytic syndrome (VAH

Latency pattern of Epstein-Barr virus an
✍ Mikio Yoshioka; Hideaki Kikuta; Nobuhisa Ishiguro; Rika Endo; Kunihiko Kobayashi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Expression of different panels of latent gene transcripts is controlled by usage of three distinct Epstein‐Barr virus (EBV) nuclear antigen (EBNA) promoters (Wp, Cp, and Qp). EBV‐associated hemophagocytic syndrome, which is often a fatal disease and generally occurs after primary EBV in

Clonal change of infiltrating T-cells in
✍ Eiichi Ishii; Nobuhiro Kimura; Koji Kato; Masahiro Sako; Mitsuyuki Nagano; Atsuk 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 2 views

## BACKGROUND. Although familial hemophagocytic lymphohistiocytosis (FHL) has been considered a T-cell disorder, to the authors' knowledge there are no previous reports on the clonal basis of FHL. In the current study the authors analyzed the clonality of T-cells in two FHL patients at the time of

Treatment of Epstein-Barr virus-associat
✍ Imashuku, Shinsaku ;Kuriyama, Kikuko ;Sakai, Rika ;Nakao, Yoshitaka ;Masuda, Shi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract ## Background Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis (EBV‐HLH), also known as EBV‐associated hemophagocytic syndrome, develops mostly in children and young adults and may be fatal. Early etoposide treatment has been confirmed to be effective in children. Howev